| 000 | 00888 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250517031830.0 | ||
| 264 | 0 | _c20160223 | |
| 008 | 201602s 0 0 eng d | ||
| 022 | _a1523-1755 | ||
| 024 | 7 |
_a10.1038/ki.2015.60 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNester, Carla M | |
| 245 | 0 | 0 |
_aManaging atypical hemolytic uremic syndrome: chapter 2. _h[electronic resource] |
| 260 |
_bKidney international _cMay 2015 |
||
| 300 |
_a882-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadministration & dosage |
| 650 | 0 | 4 |
_aAtypical Hemolytic Uremic Syndrome _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 773 | 0 |
_tKidney international _gvol. 87 _gno. 5 _gp. 882-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/ki.2015.60 _zAvailable from publisher's website |
| 999 |
_c24878182 _d24878182 |
||